RUSSELL DICKENSON: Open Payments
NPI 1497745814 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,521 in 87 payments from 18 companies in 2025. Trend: 2023 $1,404 · 2024 $1,150 · 2025 $1,521
Food & beverage: $1,521
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 21 | $410 |
| PFIZER INC. | 16 | $154 |
| Amgen Inc. | 9 | $137 |
| Novo Nordisk Inc | 7 | $128 |
| SCPHARMACEUTICALS INC. | 4 | $103 |
| E.R. Squibb & Sons, L.L.C. | 4 | $101 |
| Merck Sharp & Dohme LLC | 5 | $100 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $91 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $69 |
| Boston Scientific Corporation | 4 | $59 |
Products named: LEQVIO, ELIQUIS, Repatha, Ozempic, FUROSCIX, CAMZYOS, VERQUVO, LifeVest.
Industry payments across TN — which companies pay providers there.
